Weekly Market Outlook

Expected Nifty, Sensex may be headed Upper for the next Week

BSE Index (25863.50) :- It is improving from bottom of 24833.54. It shows towards oversold position on daily basis, towards neutral on week basis and towards oversold position on monthly basis. On upward movement, beyond 25960 it may go up to 26065 with resisting level at 26165 and then after to 26270, 26339 and 26472. On downward movement, below 25386 shows week position. All eyes on Bank Policy on Tuesday.

Nifty Future (7870.35) :- It shows rebounding effect from bottom of 7560.10. It shows towards oversold position on daily basis, towards neutral on week basis and towards oversold position on monthly basis. On upward movement, beyond 7905 it may go up to 7935, 7965, 8012, 8059, 8125. On downward movement, below 7805 it may go down to 7775, 7745 with last support at 7713.

Bank Nifty (17193.40) :- From bottom of 15793.05, it shows rebounding effect. It shows towards oversold position on daily basis, towards neutral on week basis and towards oversold position on monthly basis. On upward movement, beyond 17325 it may go up to 17415, 17530 with last resisting level at 17643. On downward movement, below 16950 it may go down to 16870 and 16750. All eyes on bank policy on Tuesday.

Comments

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News* *TCI FINANCE LTD (501242 & NSE) (31)* Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc. The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services. *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...

Value Research

Search This Blog